Daily News Podcast

An epidemic of non-alcoholic fatty liver disease

Publish date: August 20, 2018

 

Non-alcoholic fatty liver disease, or NAFLD, is the 21st century epidemic in liver disease according to Dr. Zobair Younossi speaking at the annual meeting of the American College of Physicians in New Orleans. Also today, how smoking and drinking impact risk for SLE among black women in the U.S., the FDA approves the first EpiPen generic, and final 15-year data from the veterans affairs diabetes trial. Subscribe to the MDedge Daily News wherever you get your podcasts.

Amazon Alexa

Apple Podcasts

Spotify

Recommended Reading

Variation doesn’t mean quality when it comes to diet
MDedge Internal Medicine
Breast arterial calcification, low bone mass predict CAD in women
MDedge Internal Medicine
Address physical health risks of people with SMI
MDedge Internal Medicine
Prolonged antimalarial therapy linked to elevated cardiac biomarkers, cardiomyopathy
MDedge Internal Medicine
Medicare Advantage pushback
MDedge Internal Medicine
Adult congenital heart disease guideline gets 10-year update, new classification system
MDedge Internal Medicine
Psoriasis registry study provides more data on infliximab’s infection risk
MDedge Internal Medicine
New guidelines remap adult congenital heart disease
MDedge Internal Medicine
FDA approves first EpiPen generic
MDedge Internal Medicine
Cardiovascular risk management supported for type 2 diabetes
MDedge Internal Medicine